AMGEN K A INC has a total of 16 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are CARMOT THERAPEUTICS INC, ADAIR CHARLES DAVID and HOUCK JOHN C.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 8 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Fitzpatrick David | 6 |
#2 | Mehlin Christopher | 6 |
#3 | Lim Ai Ching | 6 |
#4 | Smothers James F | 6 |
#5 | Peschon Jacques J | 6 |
#6 | Salinger David H | 5 |
#7 | Liu Dingjiang | 5 |
#8 | Baumgartner Scott Walter | 5 |
#9 | Martin David Andrew | 5 |
#10 | Huang Holly Zhuohong | 5 |
Publication | Filing date | Title |
---|---|---|
EP3185902A1 | Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy | |
AU2011203098A1 | IL-17 receptor A antigen binding proteins |